資本剰余金、研究開発費 - 化成品事業、未収入金他1件
- 【期間】
| 年度 | 資本剰余金 | 研究開発費 - 化成品事業 | 未収入金 | 退職給付に係る負債 |
|---|
| 2007/03 | 81.2億 | | - | | - | | - | |
| 2008/03 | 81.2億 | -0% | - | | 46.2億 | | - | |
| 2009/03 | 81.2億 | ±0% | - | | 51.6億 | +11.8% | - | |
| 2010/03 | 81.2億 | ±0% | - | | 28.6億 | -44.6% | - | |
| 2011/03 | 81.2億 | ±0% | - | | 41.5億 | +45.1% | - | |
| 2012/03 | 81.2億 | ±0% | - | | 37.8億 | -8.8% | - | |
| 2013/03 | 81.2億 | ±0% | - | | 33.2億 | -12.4% | - | |
| 2014/03 | 81.2億 | ±0% | - | | 49.9億 | +50.4% | 86.6億 | |
| 2015/03 | 81.2億 | ±0% | - | | 42.4億 | -15.1% | 74.3億 | -14.2% |
| 2016/03 | 81.2億 | ±0% | - | | 32.7億 | -22.9% | - | |
| 2017/03 | 81.2億 | ±0% | - | | 39.2億 | +20.1% | - | |
| 2018/03 | 81.1億 | -0.1% | - | | 31.4億 | -20% | - | |
| 2019/03 | 81.1億 | ±0% | 42.6億 | | 80.9億 | +157.6% | - | |
| 2020/03 | 81.1億 | ±0% | 45.1億 | +6% | 46.3億 | -42.8% | - | |
| 2021/03 | 81.1億 | ±0% | 45億 | -0.3% | 47.8億 | +3.2% | - | |
| 2022/03 | 81.1億 | ±0% | 44.9億 | -0.2% | 55.9億 | +17% | - | |
| 2023/03 | 81.1億 | ±0% | 48.5億 | +8.1% | 62億 | +10.9% | - | |
| 2024/03 | 81.1億 | ±0% | - | | - | | - | |
